Funded Tech Companies
Meissa Vaccines
Looking for the VC firms that provided funding to Meissa Vaccines? Morningside Group, private investors and FundRx joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Meissa Vaccines
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1100 Island Dr. 202
Redwood City, CA 94065
USA
Redwood City, CA 94065
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Meissa Vaccines is a start-up pharmaceutical development company focused on the in-licensing and advancement of vaccines for respiratory syncytial virus (RSV, the largest unmet respiratory medical need in pediatrics) and rhinovirus (leading cause of infectious disease worldwide).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/27/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Marty Moore
Chief Medical Officer
Karen Slobod
Chief Scientific Officer
Roderick Tang
VP - Operations
Janelle Muranaka
VP - Regulatory Affairs
Fiona Cameron
Company Investors
- Morningside Group (Stephanie O'Brien)
- FundRx (Gurdane Bhutani)
Browse more funded tech companies:
Share this article
About Our Venture Capital Transactions Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs